Synairgen
Trial of potential new COVID-19 treatment begins in UK
January 13, 2021Research and Development COVID-19, Synairgen, Vaccine
A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
July 20, 2020Research and Development, Sales and Marketing COVID-19, Synairgen
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
AstraZeneca forced to abandon Phase II trial
October 12, 2016Research and Development AstraZeneca, Synairgen, asthma, cold, common cold
Synairgen, a respiratory drug discovery and development company, has developed a drug, AZD9412, alongside AstraZeneca to treat and prevent severe …
AstraZeneca signs $240m asthma deal with UK biotech
June 12, 2014Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
